Immunotherapy

Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease.

Read more in the app

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

An immunotherapy to overcome resistant leukemia

Genetic signature may predict response to immunotherapy for non-small cell lung cancer

Biomarker-directed combination effective in immunotherapy-resistant lung cancer

Scientists engineer potent immune cells for 'off-the-shelf' cancer immunotherapy

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery

Drug-filled nanocapsule helps make immunotherapy more effective in mice

Why Does Immunotherapy Not Always Work? New Research Sheds Light

Immunotherapy for 'difficult to treat' lung cancer patients improves long-term survival

A two-for-one approach to boost melanoma immunotherapy

Researchers uncover potential biomarkers of positive response to immunotherapy

Study hints at how cancer immunotherapy can be safer

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

STING Like a Bee: MIT’s Revolutionary Approach to Cancer Immunotherapy

Allergic to Your Pet? This Immunotherapy May Help

To boost cancer immunotherapy's fighting power, look to the gut

New Hope for High-Risk Prostate Cancer – Promising Immunotherapy Agent Proven To Be Safe

Scientists Discover a Potential New Target for Head and Neck Cancer Immunotherapy

Vitamin D: Immunotherapy Booster Against Skin Cancer?

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers